Transcatheter Aortic Valve Replacement (TAVR) Clinical Trials

Clinical trials related to Transcatheter Aortic Valve Replacement (TAVR) Procedure

Design and Rationale of the National Multicenter Tunisian Registry of Trans Catheter Aortic Valve Implantation Registry

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Transcatheter aortic valve implantation (TAVI) has emerged as a transformative therapy for patients with severe aortic stenosis, particularly those designated high-risk or inoperable for traditional surgical valve replacement. Despite its increasing adoption worldwide, there re-mains a paucity of data regarding TAVI outcomes in Tunisian patients. In response to this gap in knowledge, the investigators propose the establishment of the Tunisian TAVI Registry, a multicenter initiative aimed at comprehensively documenting the clinical characteristics, procedural de-tails, and short- and long-term outcomes of TAVI procedures across Tunisia. The TAVI.TN registry will enroll consecutive patients undergoing TAVI procedures at participating centers across Tunisia, between 2013 and 2024 with a retrospective arm and a prospective arm. The TAVI-TN Registry represents a significant step towards enhancing our understanding of TAVI outcomes in the Tunisian population. By systematically capturing real-world data, this initiative aims to inform clinical decision-making, improve patient care, and contribute to the advancement of TAVI practices in Tunisia and beyond.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 85
Healthy Volunteers: f
View:

• \- Any Tunisian patient who was treated with TAVI implantation in Tunisia

Locations
Other Locations
Tunisia
Hôpital militaire principal d'instruction de Tunis
RECRUITING
Tunis
Contact Information
Primary
Nadhem HAJLAOUI, PI
drnadhemhajlaoui@gmail.com
+21655130873
Backup
Salem ABDESSALEM, MD
salem.abdesselem@gmail.com
+21655333282
Time Frame
Start Date: 2023-09-23
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 300
Sponsors
Leads: Les Laboratoires des Médicaments Stériles
Collaborators: Tunisian Society of Cardiology and Cardiovascular Surgery

This content was sourced from clinicaltrials.gov